Profile data is unavailable for this security.
About the company
Consun Pharmaceutical Group Ltd is a company principally engaged in manufacturing and sales of pharmaceutical products. The Company operates its businesses through two segments. Consun Pharmaceutical segment is mainly engaged in manufacturing and sells of modern Chinese medicines and medical contrast medium. Yulin Pharmaceutical segment is mainly involved in manufacturing and sells of traditional Chinese medicines. The Company's products include kidney medicines, gynaecology and paediatrics medicines, contrast medium, orthopedics medicines, dermatologic medicines, hepatobiliary medicines and others. The Company mainly operates its businesses in the domestic market.
- Revenue in HKD (TTM)3.70bn
- Net income in HKD1.14bn
- Incorporated2010
- Employees3.07k
- LocationConsun Pharmaceutical Group Ltd71 Dongpeng Avenue, East SectionEconomic and Technological DevelopmentGuangzhou Luogang DistrictGUANGZHOU 510760ChinaCHN
- Phone+86 2 082016888
- Fax+86 2 082017468
- Websitehttps://www.chinaconsun.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hbm Holdings Ltd | 904.42m | 571.13m | 10.17bn | 210.00 | 15.79 | 4.20 | 17.00 | 11.24 | 0.7406 | 0.7406 | 1.14 | 2.78 | 0.3856 | 6.32 | 32.64 | 5,797,568.00 | 24.77 | -42.87 | 30.77 | -53.24 | 92.95 | 96.12 | 64.25 | -292.58 | 6.02 | 28.63 | 0.1857 | -- | -57.43 | 47.71 | -87.81 | -- | -55.31 | -- |
| China Traditional Chinese Med Hldg CoLtd | 17.65bn | -299.94m | 10.27bn | 15.58k | -- | 0.4381 | 11.29 | 0.5819 | -0.0596 | -0.0596 | 3.51 | 4.66 | 0.4326 | 1.59 | 1.71 | 1,053,804.00 | -0.93 | 3.48 | -1.42 | 5.24 | 47.66 | 54.69 | -2.15 | 7.39 | 1.51 | 9.55 | 0.1333 | 21.27 | -8.90 | 2.89 | -95.79 | -49.14 | -15.28 | -48.82 |
| Fujian Haixi Pharmaceuticals Co Ltd | -100.00bn | -100.00bn | 10.74bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 47.39 | -- | 15.86 | -- | -- | -- |
| Luye Pharma Group Ltd | 6.99bn | 449.57m | 10.79bn | 5.12k | 22.59 | 0.6104 | 6.73 | 1.54 | 0.1195 | 0.1195 | 1.86 | 4.42 | 0.2083 | 2.42 | 2.37 | 1,356,462.00 | 1.91 | 1.98 | 3.26 | 3.16 | 66.85 | 68.37 | 9.15 | 8.04 | 1.24 | 2.35 | 0.4227 | 0.00 | -1.33 | -0.9503 | -11.40 | -19.50 | -10.95 | -- |
| Guangzhou Innogen Pharmaceutl Grp Co Ltd | -100.00bn | -100.00bn | 12.76bn | 105.00 | -- | 15.00 | -- | -- | -- | -- | -- | 1.84 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 3.39 | -- | 0.0769 | -- | -- | -- | 76.18 | -- | -- | -- |
| Everest Medicines Ltd | 964.16m | -746.10m | 13.86bn | 722.00 | -- | 2.89 | -- | 14.38 | -2.31 | -2.31 | 2.98 | 13.57 | 0.1684 | 13.97 | 3.04 | 1,449,858.00 | -13.03 | -29.28 | -14.21 | -31.67 | 69.92 | -- | -77.38 | -1,040.86 | 5.43 | -- | 0.1577 | -- | 461.16 | -- | -23.32 | -- | 16.96 | -- |
| CF PharmTech Inc | 684.00m | 31.43m | 14.21bn | 574.00 | 452.41 | 13.10 | 138.36 | 20.78 | 0.0763 | 0.0763 | 1.66 | 2.64 | -- | -- | -- | -- | -- | -- | -- | -- | 80.18 | -- | 4.60 | -- | 1.89 | -- | 0.076 | -- | 9.23 | -- | -33.53 | -- | -- | -- |
| Sihuan Pharmaceutical Holdings Group Ltd | 2.38bn | -91.33m | 14.91bn | 2.77k | -- | 3.02 | -- | 6.28 | -0.0098 | -0.0098 | 0.2575 | 0.5402 | 0.1894 | 1.49 | 3.86 | 890,789.90 | -3.05 | -3.60 | -5.01 | -5.05 | 66.29 | 73.13 | -16.08 | -19.74 | 1.61 | -1.36 | 0.1606 | -- | 2.18 | -7.96 | -301.10 | -- | -20.58 | 3.60 |
| Consun Pharmaceutical Group Ltd | 3.70bn | 1.14bn | 15.22bn | 3.07k | 13.59 | 3.13 | 12.49 | 4.11 | 1.33 | 1.33 | 4.31 | 5.78 | 0.5642 | 2.35 | 12.33 | 1,169,558.00 | 17.60 | 14.71 | 24.67 | 22.82 | 76.62 | 75.04 | 31.20 | 29.56 | 3.32 | -- | 0.0517 | 40.93 | 14.56 | 11.42 | 16.05 | 62.72 | -9.54 | 25.83 |
| Ascletis Pharma Inc | 2.68m | -292.85m | 17.42bn | 208.00 | -- | 7.48 | -- | 6,507.62 | -0.2994 | -0.2994 | 0.0028 | 2.20 | 0.0011 | 0.2668 | 11.59 | 11,590.66 | -12.10 | -8.46 | -12.73 | -8.80 | 36.21 | 7.91 | -10,937.78 | -522.12 | 14.53 | -- | 0.0023 | -- | -97.73 | -62.52 | -107.95 | -- | -40.26 | -- |
| Zai Lab Ltd | 3.45bn | -1.62bn | 17.59bn | 1.87k | -- | 2.90 | -- | 5.10 | -1.52 | -1.52 | 3.21 | 5.37 | 0.4119 | 3.19 | 6.53 | -- | -19.29 | -33.80 | -27.61 | -39.12 | 61.52 | 64.07 | -46.83 | -186.77 | 2.68 | -- | 0.2108 | -- | 49.59 | 98.38 | 23.17 | -- | 32.19 | -- |
| Vigonvita Life Sciences Co Ltd | -100.00bn | -100.00bn | 18.44bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -94.07 | -- | -1,848.73 | -- | -- | -- |
| Ab&B Bio Tech Co Ltd JS | 366.68m | -254.18m | 20.26bn | 583.00 | -- | 531.53 | -- | 55.26 | -0.646 | -0.646 | 0.932 | 0.0969 | -- | -- | -- | -- | -- | -- | -- | -- | 67.29 | -- | -69.32 | -- | 0.3162 | -9.49 | 0.9646 | -- | 397.65 | -- | 39.09 | -- | -- | -- |
Data as of Feb 13 2026. Currency figures normalised to Consun Pharmaceutical Group Ltd's reporting currency: Hong Kong Dollar HKD
14.65%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fidelity Management & Research Co. LLCas of 02 Feb 2026 | 38.88m | 4.58% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 18.13m | 2.14% |
| FIAM LLCas of 02 Feb 2026 | 14.34m | 1.69% |
| Goldman Sachs Asset Management LPas of 12 Feb 2026 | 10.57m | 1.25% |
| Dimensional Fund Advisors LPas of 30 Nov 2025 | 10.10m | 1.19% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 9.26m | 1.09% |
| APG Asset Management NVas of 31 Dec 2024 | 6.91m | 0.81% |
| BlackRock Fund Advisorsas of 06 Feb 2026 | 5.94m | 0.70% |
| Grantham, Mayo, Van Otterloo & Co. LLCas of 30 Nov 2025 | 5.64m | 0.67% |
| Robeco Institutional Asset Management BVas of 31 Dec 2025 | 4.63m | 0.55% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
